Top Markets
Coin of the day
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc.

NBSE
Classificação em ações #39175
Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics,... Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics, Inc. is dedicated to pioneering therapeutic solutions for rare genetic disorders and various cancers stemming from aberrant genes. At the core of its approach is the proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform. This technology is being utilized to target ailments such as Huntington's disease (HD) and myotonic dystrophy, in addition to a broader spectrum of genetic conditions and applications within oncology. The company's leading therapeutic candidates encompass NT0100, a PATrOL-powered anti-gene therapy for Huntington's disease; NT0200, another PATrOL-enabled anti-gene solution for myotonic dystrophy type 1; and NT0300, a PATrOL-based treatment specifically engineered to address the mutated KRAS gene. NeuBase Therapeutics, Inc. maintains its headquarters in Pittsburgh, Pennsylvania.
Preço da ação
$0.378
Última sincronização: 2024-05-24
Valor de mercado
$618.41K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar NeuBase Therapeutics, Inc. (NBSE)

Categoria

Preço NBSE com a capitalização de mercado de B
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
NBSE
$0.378
Capitalização de mercado de NeuBase Therapeutics, Inc.(NBSE)
Valor de mercado: $618.41K
Em August 2026, NeuBase Therapeutics, Inc. tem uma capitalização de mercado de $618.41K. Isso faz com que NeuBase Therapeutics, Inc. seja a 39175th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de NeuBase Therapeutics, Inc. de 2004 a 2026
NBSE comparado com o topo de 5 mais populares stocks
Preço para NBSE Ativo B Capitalização de mercado de B Resultados
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$3,343,238 $618.41K
$5.470T +884,454,463.65%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,730,484 $618.41K
$4.467T +722,350,064.17%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,551,581 $618.41K
$4.174T +675,021,304.38%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$2,261,661 $618.41K
$3.700T +598,322,901.89%
NeuBase Therapeutics, Inc. NeuBase Therapeutics, Inc.
$1,744,708 $618.41K
$2.854T +461,562,929.50%